It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: BatSars
www.contractsfinder.service.gov.uk...
I wonder why they would be looking to secure £3.1b worth of anticoagulants .... maybe it's due to the clot shot?
originally posted by: BatSars
www.contractsfinder.service.gov.uk...
I wonder why they would be looking to secure £3.1b worth of anticoagulants .... maybe it's due to the clot shot?
www.rbractive.com...
This shows that between 1/2018 and 1/2019, ~£66 million was spent on DVT or pulmonary embolism and they suspect it will cost ~$200m a year now, yet here the govt. is asking for £3.1b for anticoagulants.
Don't listen to what they say, watch what they do. This is what they're doing. This speaks louder than VAERS or a Yellow Card system ever could. Money does talk.
originally posted by: BatSars
It's in the 2nd link. 2018-2019, they spent 66m, but recalculations came to 208m per year. That means for 3.1b, they're either increasing purchases by 14x or they're buying 14 years worth.
a reply to: putnam6
originally posted by: BatSars
It's in the 2nd link. 2018-2019, they spent 66m, but recalculations came to 208m per year. That means for 3.1b, they're either increasing purchases by 14x or they're buying 14 years worth.
a reply to: putnam6
originally posted by: putnam6
originally posted by: BatSars
It's in the 2nd link. 2018-2019, they spent 66m, but recalculations came to 208m per year. That means for 3.1b, they're either increasing purchases by 14x or they're buying 14 years worth.
a reply to: putnam6
Thanks that's the perspective needed
Sounds like that's a load of coagulants to order for one time.
Used to we had journalists that would ask the right person questions about this.
originally posted by: bastion
originally posted by: BatSars
It's in the 2nd link. 2018-2019, they spent 66m, but recalculations came to 208m per year. That means for 3.1b, they're either increasing purchases by 14x or they're buying 14 years worth.
a reply to: putnam6
It doesn't really.
The £66M figure is the cost of hospial attendances for only two conditions in less than a third of hospitals.
It's not a figure for the ammount spent on anti-coagulant drugs and prescriptions which is what the contract tender is for.
originally posted by: BatSars
originally posted by: bastion
originally posted by: BatSars
It's in the 2nd link. 2018-2019, they spent 66m, but recalculations came to 208m per year. That means for 3.1b, they're either increasing purchases by 14x or they're buying 14 years worth.
a reply to: putnam6
It doesn't really.
The £66M figure is the cost of hospial attendances for only two conditions in less than a third of hospitals.
It's not a figure for the ammount spent on anti-coagulant drugs and prescriptions which is what the contract tender is for.
But the other amount is. I gave two costs and the 2nd cost has been confirmed through extrapolations I've read elsewhere. If you have evidence to the contrary, please source that instead of just writing it.
www.leeds.ac.uk...
I did find this, however, which puts the number at 789m per year, which would put the above # at right on the money. Not sure where the discrepancy here exists, but will keep digging!
And this here also confirms a ~700m cost per year: www.valueinhealthjournal.com...(19)30229-3/fulltext
So the above purchase could very well be in line with the normal (+-100m).
originally posted by: IAMTAT
Blood Clots and Micro-clotting...coming soon to "vaccinated" everywhere.